Fingerprint
Dive into the research topics where Asher A Chanan Khan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
Therapeutic implication of CD38 in CLL
Chanan Khan, A. A. (PI) & Chini, E. N. (CoPI)
9/4/19 → 8/31/24
Project: Research project
-
VACCINE FOR PATIENTS WITH NON HODGKINS LYMPHOMA
Chanan Khan, A. A. (PI) & Bernstein, S. H. (CoPI)
9/18/00 → 9/1/03
Project: Research project
-
Number needed to treat to avoid progression and death and cost analysis: zanubrutinib versus acalabrutinib in relapsed/refractory chronic lymphocytic leukemia
Shadman, M., Chanan-Khan, A., Campbell, D., Xue, M., Massoudi, M., Williams, R., Yang, K. & Tam, C. S., 2026, In: Future Oncology. 22, 3, p. 339-348 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front-Line Daratumumab Lenalidomide and Dexamethasone
Parrondo, R. D., de Menezes, R. C. B., Sledge, H., Nayyar, M., Yadav, K., Bergsagel, L., Fonseca, R., Kapoor, P., Buadi, F., Gertz, M. A., Dispenzieri, A., Roy, V., Abdallah, N., Chhabra, S., Rajkumar, S. V., Gonsalves, W. I., Cook, J., Kumar, S., Chanan-Khan, A. A. & Ailawadhi, S., Apr 2026, In: American journal of hematology. 101, 4, p. 884-888 5 p.Research output: Contribution to journal › Letter › peer-review
-
Number needed to treat and associated cost analysis of zanubrutinib vs ibrutinib in chronic lymphocytic leukemia
Chanan-Khan, A., Hanna, K., Xue, M., Massoudi, M., Balk, M., Gani, R., Piran, H. Z. & Yang, K., May 2025, In: Journal of Managed Care and Specialty Pharmacy. 31, 5, p. 482-490 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience
Parrondo, R. D., Das, S., Sledge, H., Bergsagel, L., Fonseca, R., Leung, N., Kapoor, P., Gertz, M., Buadi, F., Dispenzieri, A., Elliott, J., Fernandez, A., Flott, C., Chanan-Khan, A. A., Roy, V. & Ailawadhi, S., Dec 2025, In: Blood cancer journal. 15, 1, 100.Research output: Contribution to journal › Letter › peer-review
Open Access -
Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study
Davids, M. S., Chanan-Khan, A., Ailawadhi, S., Ivanov, V., Usenko, G., Nogaieva, L., Kryachock, I., Muzhychuk, I., Perekhrestenko, T., Kyselova, O., Myasnikov, A., Lukavetskyy, L., Uspenskaya, O., Marlton, P., Proydakov, A., Borisenkova, E., Winter, A., Siddiqi, T., Lysa, T. & Bakirov, B. & 20 others, , Dec 12 2025, In: Med. 6, 12, 100885.Research output: Contribution to journal › Article › peer-review